InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
15
T+90 hit rate
0%
T+90 mean return
-43.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Shah Gaurav, Chief Executive Officer. Director active across 1 company, notably Rocket Pharmaceuticals, INC.. Cumulatively, 26 filings have been published. Breakdown: 2 buys · 15 sells. Total volume traded: €1.9m. History available since 7 February 2022. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shah Gaurav
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
2,293 shares@ US$3.381Common StockSEC:0001140361-26-033913:0
2,837 shares@ US$3.3810.0025% mcap0.4% of flowCommon StockSEC:0001140361-26-033417:0
2,728 shares@ US$3.6060.0024% mcap1.2% of flowCommon StockSEC:0001140361-26-021315:0
5,990 shares@ US$3.3380.9% of flowCommon StockSEC:0001140361-26-006326:0
12,279 shares@ US$3.3121.8% of flowCommon StockSEC:0001140361-26-006043:0
286,028 shares0Common StockSEC:0001140361-26-005412:0
6,276 shares@ US$2.9830.9% of flowCommon StockSEC:0001140361-25-042855:0
2,234 shares@ US$3.050.3% of flowCommon StockSEC:0001140361-25-032089:0
2,253 shares@ US$6.4460.6% of flowCommon StockSEC:0001140361-25-020160:0
3,621 shares@ US$6.5281.0% of flowCommon StockSEC:0001140361-25-019899:0
20,000 shares@ US$5.084.1% of flowCommon StockSEC:0001140361-25-013804:0
Canonical exit: 9 Jul 2025 (T+90)
16,303 shares@ US$10.587.5% of flowCommon StockSEC:0001140361-25-005844:0
81,655 shares0Common StockSEC:0001140361-25-004296:0
11,091 shares@ US$13.0546.2% of flowCommon StockSEC:0001140361-24-047755:0
9,650 shares@ US$18.5047.4% of flowCommon StockSEC:0001140361-24-037932:0
7,979 shares0Common StockSEC:0001140361-24-026878:0
20,272 shares@ US$29.83825.5% of flowCommon StockSEC:0001140361-24-008886:0
46,828 shares0Common StockSEC:0001140361-24-008359:0
7,979 shares0Common StockSEC:0001140361-23-053709:0
4,767 shares@ US$15.4713.1% of flowCommon StockSEC:0001140361-23-040694:0
7,979 shares0Common StockSEC:0001140361-23-039901:0
4,122 shares@ US$21.3753.7% of flowCommon StockSEC:0001140361-23-025742:0
7,979 shares0Common StockSEC:0001140361-23-025133:0
12,194 shares@ US$19.069.9% of flowCommon StockSEC:0001140361-23-008102:0
31,440 shares0Common StockSEC:0001140361-23-008098:0
25 of 26 declarations
About Shah Gaurav
Shah Gaurav is Directeur Général and CEO of Rocket Pharmaceuticals, INC. He has 24 filings in total, and across the 24 sampled filings between 2022-02-08 and 2026-05-14, purchases amount to EUR 423298 and sales to EUR 1502399, with cession as the dominant transaction type.
